| Primary |
| Rheumatoid Arthritis |
14.1% |
| Hypertension |
9.8% |
| Gastrooesophageal Reflux Disease |
8.5% |
| Acute Lymphocytic Leukaemia |
7.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.8% |
| Prophylaxis |
6.4% |
| Dyspepsia |
5.6% |
| Depression |
4.7% |
| Pain |
4.7% |
| Sciatica |
4.7% |
| Abdominal Pain Upper |
4.3% |
| Diabetes Mellitus |
3.0% |
| Hypercholesterolaemia |
3.0% |
| Anxiety |
2.6% |
| Hiatus Hernia |
2.6% |
| Induction Of Anaesthesia |
2.6% |
| Suicide Attempt |
2.6% |
| Essential Hypertension |
2.1% |
| Multiple Myeloma |
2.1% |
| Obesity |
2.1% |
|
| Renal Failure Acute |
10.5% |
| Cytolytic Hepatitis |
9.3% |
| Thrombocytopenia |
9.3% |
| Pyrexia |
8.1% |
| Acute Generalised Exanthematous Pustulosis |
7.0% |
| Drug Interaction |
5.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.8% |
| Urticaria |
5.8% |
| Vomiting |
5.8% |
| Cryptogenic Organising Pneumonia |
3.5% |
| Hyponatraemia |
3.5% |
| Neuropathy Peripheral |
3.5% |
| Pruritus |
3.5% |
| Rhabdomyolysis |
3.5% |
| Tubulointerstitial Nephritis |
3.5% |
| Convulsion |
2.3% |
| Drug Exposure During Pregnancy |
2.3% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.3% |
| Dyspepsia |
2.3% |
| Eosinophilia |
2.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
38.4% |
| Product Used For Unknown Indication |
11.4% |
| Rheumatoid Arthritis |
5.9% |
| Hypertension |
5.7% |
| Prophylaxis |
5.4% |
| Unevaluable Event |
4.3% |
| Pain |
3.8% |
| Gastrooesophageal Reflux Disease |
3.5% |
| Acute Lymphocytic Leukaemia |
3.3% |
| Depression |
2.4% |
| Myocardial Infarction |
2.4% |
| Diabetes Mellitus |
2.2% |
| Anxiety |
1.7% |
| Cord Blood Transplant Therapy |
1.7% |
| Abdominal Pain Upper |
1.6% |
| Hypercholesterolaemia |
1.3% |
| Hypothyroidism |
1.2% |
| Infection Prophylaxis |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Cytomegalovirus Infection |
1.1% |
|
| Thrombocytopenia |
19.0% |
| Acute Generalised Exanthematous Pustulosis |
9.2% |
| Toxic Skin Eruption |
6.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.9% |
| Peritoneal Haemorrhage |
5.9% |
| Urinary Retention |
5.2% |
| Agranulocytosis |
4.6% |
| Neutropenia |
4.6% |
| Vomiting |
4.6% |
| Hepatitis |
3.9% |
| Renal Failure Acute |
3.9% |
| Vertigo |
3.9% |
| Condition Aggravated |
3.3% |
| Cytolytic Hepatitis |
3.3% |
| Urine Amylase Increased |
3.3% |
| Hyponatraemia |
2.6% |
| Pyrexia |
2.6% |
| Sepsis |
2.6% |
| Tachycardia |
2.6% |
| Thrombotic Microangiopathy |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
35.1% |
| Product Used For Unknown Indication |
21.9% |
| Hypertension |
6.7% |
| Rheumatoid Arthritis |
5.9% |
| Prophylaxis |
4.5% |
| Hiv Infection |
3.3% |
| Pain |
3.0% |
| Renal Transplant |
1.8% |
| Acute Myeloid Leukaemia |
1.7% |
| Osteoporosis |
1.7% |
| Unevaluable Event |
1.7% |
| Depression |
1.7% |
| Premedication |
1.6% |
| Ill-defined Disorder |
1.5% |
| Acute Lymphocytic Leukaemia |
1.5% |
| Atrial Fibrillation |
1.5% |
| Multiple Myeloma |
1.4% |
| Dyslipidaemia |
1.2% |
| Breast Cancer |
1.2% |
| Insomnia |
1.2% |
|
| Renal Failure Acute |
13.4% |
| Thrombocytopenia |
12.4% |
| Pyrexia |
6.7% |
| Renal Failure |
6.7% |
| Vomiting |
6.7% |
| General Physical Health Deterioration |
5.0% |
| Rhabdomyolysis |
5.0% |
| Lung Disorder |
4.7% |
| Pulmonary Embolism |
4.5% |
| Toxic Skin Eruption |
4.2% |
| Weight Decreased |
4.0% |
| Pancreatitis Acute |
3.7% |
| Malaise |
3.2% |
| Orthostatic Hypotension |
3.0% |
| Somnolence |
3.0% |
| Transaminases Increased |
3.0% |
| Weight Increased |
3.0% |
| Tachycardia |
2.7% |
| Cytolytic Hepatitis |
2.5% |
| Neutropenia |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
28.3% |
| Hypertension |
13.0% |
| Product Used For Unknown Indication |
10.9% |
| Pain |
8.7% |
| Major Depression |
4.3% |
| Musculoskeletal Pain |
4.3% |
| Agitation |
2.2% |
| Atrial Fibrillation |
2.2% |
| Breast Cancer |
2.2% |
| Cardiac Failure |
2.2% |
| Chronic Myeloid Leukaemia |
2.2% |
| Cryptogenic Organising Pneumonia |
2.2% |
| Depression |
2.2% |
| Gastric Disorder |
2.2% |
| Gastric Ulcer |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Myocardial Infarction |
2.2% |
| Prophylaxis |
2.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
| Stent Placement |
2.2% |
|
| Hypotension |
12.5% |
| Myocardial Infarction |
12.5% |
| Deep Vein Thrombosis |
6.3% |
| Drug Interaction |
6.3% |
| Inappropriate Antidiuretic Hormone Secretion |
6.3% |
| Overdose |
6.3% |
| Pneumonia Aspiration |
6.3% |
| Pulmonary Embolism |
6.3% |
| Road Traffic Accident |
6.3% |
| Tachycardia |
6.3% |
| Thrombocytopenia |
6.3% |
| Thrombosis |
6.3% |
| Traumatic Haematoma |
6.3% |
| Wrong Drug Administered |
6.3% |
|
